Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Johnson & Johnson gains CE mark approval for catheter capable of radiofrequency, PFA ablation
A new catheter from Johnson & Johnson MedTech is now approved to treat cardiac arrhythmias in Europe. Could FDA approval be on the horizon?
Robotic mitral repair compares favorably to surgery—but some concerns remain
Robotic-assisted mitral valve repair is associated with short-term outcomes comparable to conventional surgery, according to a new analysis of more than 40,000 patients. Robotic treatment also helps patients spend less time in the hospital, but the costs are much higher.
FDA has now cleared more than 1,000 AI models, including many in cardiology
Cardiology is the medical speciality with the second most FDA clearances overall.
Altered brain structure may play a role in eating disorders, MRI data suggest
Experts recently uncovered evidence suggesting behaviors such as undereating, binging and purging could be owed to anatomical alterations in parts of the brain.
Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.

CT procedure shown to reduce need for invasive cardiac testing

In a study, CT-FFR was shown to reduce the need for invasive tests to measure coronary artery blockage from 74.5% to 25.5%.

April 16, 2024

New cardiac imaging strategy could reduce ICA, PCI rates

Radiologists with Massachusetts General Hospital found that the selective use of cardiac CT and AI-based CAD evaluations could make a significant impact on patient care.

April 16, 2024

PHOTO GALLERY: Highlights from ACC.24 in Atlanta

ACC.24, the American College of Cardiology's annual meeting in Atlanta, featured the latest in cardiovascular research and technologies. Representatives from Cardiovascular Business were there in person to take in the excitement.

April 16, 2024

FDA announces new recall of Abbott’s HeartMate LVADs after 14 deaths

The issue at the center of this recall, which includes both the HeartMate II and HeartMate 3 LVAD, is the gradual buildup of biological materials. This can impact the device's performance, creating a heightened risk of injury or death.

April 15, 2024

Measles is on the march from airports to places near us

The U.S. eradicated measles in 2000. Today it’s making a comeback. What explains the unhappy revival?

April 15, 2024

PET/MRI may reduce unnecessary prostate biopsies by 83%

A study out of China found most patients biopsied for prostate lesions did not have clinically significant cancer, calling the clinical ranking systems into question.

April 12, 2024

Video of Gregg Stone, MD, explaining the late-breaking RELIEVE-HF trial he presented at ACC.24 this week. #ACC24 #ACC2024

Inter-atrial shunt in RELIEVE-HF improves symptoms in HFrEF, but not HFpEF

Gregg Stone, MD, explains the details of the late-breaking RELIEVE-HF trial at ACC.24, where an inter-atrial shunt improved symptoms in HFrEF, but not in HFpEF patients.

April 12, 2024

AI able to assess invasiveness of lung lesions to aid in surgery

In a study, the most accurate model combined deep-learning with a radionomics approach.

April 11, 2024

Clinical

Johnson & Johnson gains CE mark approval for catheter capable of radiofrequency, PFA ablation

Robotic mitral repair compares favorably to surgery—but some concerns remain

FDA has now cleared more than 1,000 AI models, including many in cardiology

Altered brain structure may play a role in eating disorders, MRI data suggest

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications